About Susmed Responsible pharmaceutical communication

Ethics, compliance and responsible information

A clear view of how Susmed approaches responsible product information, privacy and ethical engagement.

Susmed is building a responsible information system around approved product labels, controlled review, privacy safeguards and transparent partner communication.

Approved and verifiable

Medicine information should be consistent with current approved material, balanced, reviewable and supported by an identifiable source.

Audience appropriate

Professional product information is separated from general company information intended for the public.

Controlled publishing

Product information is reviewed, dated and connected to a traceable source before approval.

Privacy by purpose

Personal information is collected only for a stated enquiry or follow-up purpose and should be retained only as needed.

01

Our operating commitments

  • No medicine should be promoted before the relevant approval or beyond the terms of its approved information.
  • Claims and comparisons should be factual, balanced, current, fair, and capable of substantiation.
  • Prescription medicine information should be directed to an appropriate professional audience.
  • Website content, product labels, supporting evidence, and review dates should remain traceable through the CMS.
Document control

Controlled company documents

Controlled licences, certificates, self-declarations and policies are published here through Susmed's approved document-release process.

Controlled publication processCurrent approved company documents are released here through Susmed's document-control workflow.